Global Whole Genome and Exome Sequencing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Whole Genome and Exome Sequencing Market Research Report 2024
Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
According to MRAResearch’s new survey, global Whole Genome and Exome Sequencing market is projected to reach US$ 623.8 million in 2033, increasing from US$ 296 million in 2022, with the CAGR of 11.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Whole Genome and Exome Sequencing market research.
Key companies engaged in the Whole Genome and Exome Sequencing industry include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Novogene Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Whole Genome and Exome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Whole Genome and Exome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Whole Genome and Exome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Segment by Type
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Whole Genome and Exome Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Whole Genome and Exome Sequencing market is projected to reach US$ 623.8 million in 2033, increasing from US$ 296 million in 2022, with the CAGR of 11.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Whole Genome and Exome Sequencing market research.
Key companies engaged in the Whole Genome and Exome Sequencing industry include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Novogene Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Whole Genome and Exome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Whole Genome and Exome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Whole Genome and Exome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Segment by Type
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Segment by Application
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Whole Genome and Exome Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source